have once again convincingly emphasized the pregabalin potential of misuse. However, after a decade of intensive pregabalin-focused studies, still a few issues remain open.
Indeed, the first to explore is why a potential for misuse for pregabalin is there. Is it related to a direct/indirect dopaminergic activity similar to remaining drugs of misuse? Why is pregabalin being typically misused in combination with opiates/opioids? Pregabalin is a known inhibitor of α2δ-subunit-containing voltage-dependent calcium channels. 2 The entry of calcium ions into neurons allows the process of vesicle fusion with the cell membrane, which facilitates proper release of neurotransmitters. Ultimately, the potent binding of pregabalin at the calcium channel will reduce the release of excitatory molecules (eg, glutamate, noradrenaline, and substance P, but not dopamine), acting against aberrant neuronal stimulation.
2 Several addictive drugs have in common that they increase the extracellular dopaminergic activity in the mesolimbic reward system. 3 In rats, conditioned place preference was, however, induced only with high intraperitoneal (but not oral) pregabalin doses, restricting the ability to develop a substantial addictive power. 4 Accordingly, patients reported pleasant stimulation and euphoria when using supratherapeutic/mega (eg 1500-12 000 mg) pregabalin dosages. 5, 6 Hence, one could wonder if there may be a different/unclear range of neurotransmitter involvement, and receptors' activation intensity, in high/very high pregabalin dosage ingestion. Overall, similar to what was observed with a range of further medications (eg, venlafaxine, bupropion, quetiapine, and loperamide), 6 it has been suggested that gabapentinoids may induce a "liking" (euphoric high) subjective feeling, due to their gamma-aminobutyric acid (GABA)-mimetic action, but more limited levels of "wanting"/behavioral dependence. 7 Cairns et al 1 have identified that pregabalin was typically ingested in combination with opiates/opioids.
Indeed, opioids may well be prescribed to potentiate gabapentinoid analgesic effects for treating specific medical conditions/intractable pain. 5 However, pregabalin may clinically counteract the opioids' withdrawal effects while presenting as well with potentiating effects when given to mice with existing opioid levels. for their pregabalin addiction or pregabalin relapses after detoxification. 7 Although observations of behavioral dependence were described in patients who had no prior substance abuse history, these cases appeared to be quite rare. However, different from clonazepam, high-dosage pregabalin has been anecdotally described as an "ideal psychotropic drug" for recreational purposes to achieve specific mindsets, including relaxation and disinhibition, for example, alcohol/GHB/benzodiazepine-like effects mixed with euphoria; to achieve entactogenic feelings/dissociation; and to cope with opiate/opioid withdrawal. 10, 12 Consistent with these concerns, the rate of pregabalin-related ambulance attendances has recently increased 13 and growing numbers of deaths have been associated with pregabalin misuse. These misusing levels mostly occur together with other sedatives, such as benzodiazepines, alcohol, and opioids. 13, 14 In all these polydrug intoxication cases, pregabalin, while contributing in terms of overall
